0001493152-21-020490.txt : 20210817 0001493152-21-020490.hdr.sgml : 20210817 20210817215611 ACCESSION NUMBER: 0001493152-21-020490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200813 FILED AS OF DATE: 20210817 DATE AS OF CHANGE: 20210817 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Drexler Ryan Charles CENTRAL INDEX KEY: 0001648033 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-53166 FILM NUMBER: 211184917 MAIL ADDRESS: STREET 1: 525 CHALETTE DRIVE CITY: BEVERLY HILLS STATE: CA ZIP: 90201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MusclePharm Corp CENTRAL INDEX KEY: 0001415684 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770664193 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 BUSINESS PHONE: (800) 210-7369 MAIL ADDRESS: STREET 1: 4721 IRONTON STREET CITY: DENVER STATE: CO ZIP: 80239 FORMER COMPANY: FORMER CONFORMED NAME: Tone in Twenty DATE OF NAME CHANGE: 20071018 4 1 ownership.xml X0306 4 2020-08-13 0 0001415684 MusclePharm Corp MSLP 0001648033 Drexler Ryan Charles C/O MUSCLEPHARM CORPORATION 3753 HOWARD HUGHES PARKWAY SUITE-200-849 LAS VEGAS NV 89169 1 1 1 0 CEO Convertible Promissory Note 2021-08-13 4 J 0 2457549 A 2022-07-14 Common Stock 2457549 D On October 15, 2020, Mr. Drexler entered into a convertible secured promissory note agreement with a principal amount of $2,457,549 with the Company. (the "October 2020 Convertible Note"). Both the principal and any accrued but unpaid interest under the October 2020 Convertible Note will become due and payable on July 14, 2022, unless earlier converted or repaid. Closing price on October 15, 2021 Determined on October 15, 2021 /s/ Ryan Charles Drexler 2021-08-17